These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25457475)

  • 21. The dawn phenomenon in type 2 diabetes: its association with glucose excursions and changes after oral glucose-lowering drugs.
    Wang JS; Lee IT; Lee WJ; Lin SD; Su SL; Tu ST; Lin SY; Sheu WH
    Ther Adv Chronic Dis; 2021; 12():20406223211033674. PubMed ID: 34394904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The dawn phenomenon revisited: implications for diabetes therapy.
    Carroll MF; Schade DS
    Endocr Pract; 2005; 11(1):55-64. PubMed ID: 16033737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accuracy and precision of glucose monitoring are relevant to treatment decision-making and clinical outcome in hospitalized patients with diabetes.
    Voulgari C; Tentolouris N
    Diabetes Technol Ther; 2011 Jul; 13(7):723-30. PubMed ID: 21699417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimates of the relative and absolute diurnal contributions of fasting and post-prandial plasma glucose over a range of hyperglycaemia in type 2 diabetes.
    Peter R; Dunseath G; Luzio SD; Owens DR
    Diabetes Metab; 2013 Sep; 39(4):337-42. PubMed ID: 23993831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes.
    Del Favero S; Place J; Kropff J; Messori M; Keith-Hynes P; Visentin R; Monaro M; Galasso S; Boscari F; Toffanin C; Di Palma F; Lanzola G; Scarpellini S; Farret A; Kovatchev B; Avogaro A; Bruttomesso D; Magni L; DeVries JH; Cobelli C; Renard E;
    Diabetes Obes Metab; 2015 May; 17(5):468-76. PubMed ID: 25600304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of free-living pattern of sedentary behaviour on intra-day glucose regulation in type 2 diabetes.
    Paing AC; McMillan KA; Kirk AF; Collier A; Hewitt A; Chastin SFM
    Eur J Appl Physiol; 2020 Jan; 120(1):171-179. PubMed ID: 31705275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of a diabetes-specific nutritional shake to replace a daily breakfast and afternoon snack improves glycemic responses assessed by continuous glucose monitoring in people with type 2 diabetes: a randomized clinical pilot study.
    Mustad VA; Hegazi RA; Hustead DS; Budiman ES; Rueda R; Maki K; Powers M; Mechanick JI; Bergenstal RM; Hamdy O
    BMJ Open Diabetes Res Care; 2020 Jul; 8(1):. PubMed ID: 32718934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting Immunological Risk for Stage 1 and Stage 2 Diabetes Using a 1-Week CGM Home Test, Nocturnal Glucose Increments, and Standardized Liquid Mixed Meal Breakfasts, with Classification Enhanced by Machine Learning.
    Montaser E; Breton MD; Brown SA; DeBoer MD; Kovatchev B; Farhy LS
    Diabetes Technol Ther; 2023 Sep; 25(9):631-642. PubMed ID: 37184602
    [No Abstract]   [Full Text] [Related]  

  • 29. Humalog Mix25 improves 24-hour plasma glucose profiles compared with the human insulin mixture 30/70 in patients with type 2 diabetes mellitus.
    Herz M; Arora V; Campaigne BN; Scholtz HE; Potgieter MA; Mollentze W
    S Afr Med J; 2003 Mar; 93(3):219-23. PubMed ID: 12768948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequency and severity of the dawn phenomenon in type 2 diabetes: relationship to age.
    Monnier L; Colette C; Sardinoux M; Baptista G; Regnier-Zerbib A; Owens D
    Diabetes Care; 2012 Dec; 35(12):2597-9. PubMed ID: 22991448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The dawn or Somogyi phenomenon? High morning fasting blood sugar values in young type-1 diabetics].
    Holl RW; Heinze E
    Dtsch Med Wochenschr; 1992 Oct; 117(40):1503-7. PubMed ID: 1396135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of dialysis on the glucose profile in patients with diabetes: usefulness of continuous glucose monitoring.
    Chantrel F; Sissoko H; Képénékian L; Smagala A; Meyer L; Imhoff O; Serb L; Fleury D; Dorey F; Krummel T; Le Floch JP; Kessler L
    Horm Metab Res; 2014 Oct; 46(11):810-3. PubMed ID: 24627097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fasting glucose level is associated with nocturnal hypoglycemia in elderly male patients with type 2 diabetes.
    Fang F; Xiao H; Li C; Tian H; Li J; Li Z; Cheng X
    Aging Male; 2013 Sep; 16(3):132-6. PubMed ID: 23876123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-Intensity Resistance Exercise Reduces Hyperglycemia and Enhances Glucose Control Over a 24-Hour Period in Women With Type 2 Diabetes.
    Cruz LCD; Teixeira-Araujo AA; Passos Andrade KT; Rocha TCOG; Puga GM; Moreira SR
    J Strength Cond Res; 2019 Oct; 33(10):2826-2835. PubMed ID: 30517087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycemic variability and its responses to intensive insulin treatment in newly diagnosed type 2 diabetes.
    Zhou J; Jia W; Bao Y; Ma X; Lu W; Li H; Hu C; Xiang K
    Med Sci Monit; 2008 Nov; 14(11):CR552-8. PubMed ID: 18971871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A single-center, randomized, double-blind, three-way crossover study examining postchallenge glucose responses to human insulin 70/30 and insulin lispro fixed mixtures 75/25 and 50/50 in patients with type 2 diabetes mellitus.
    Schwartz S; Zagar AJ; Althouse SK; Pinaire JA; Holcombe JH
    Clin Ther; 2006 Oct; 28(10):1649-57. PubMed ID: 17157120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuous glucose monitoring in type 2 diabetes.
    Harman-Boehm I
    Diabetes Res Clin Pract; 2008 Dec; 82 Suppl 2():S118-21. PubMed ID: 19027978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The dawn phenomenon across the glycemic continuum: Implications for defining dysglycemia.
    Li C; Ma X; Yin J; Mo Y; Zhang L; Lu J; Lu W; Bao Y; Vigersky RA; Zhou J; Jia W
    Diabetes Res Clin Pract; 2020 Aug; 166():108308. PubMed ID: 32650035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Occurrence of early-morning hyperglycemia (dawn phenomenon) in patients with diabetes mellitus type 1 and 2].
    Jasik M; Orłowska K
    Pol Arch Med Wewn; 1989 Apr; 81(4):207-13. PubMed ID: 2696935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical diagnosis for dusk phenomenon of diabetes.
    Du S; Shi MJ; Sun ZZ; Li W
    Medicine (Baltimore); 2018 Aug; 97(34):e11873. PubMed ID: 30142783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.